Skip to main content

For Amarin to immediately pursue an Authorized Generic version of Vascepa

22 Comments

S
Stock Holder
5 years ago

please consider something to make this right.

S
Surjyendu Dhal
5 years ago

Ag

S
Sree
5 years ago Featured

Negotiate with generics for win/win strategy for market maturation with limits to market share. Please sell the company to BP for AG strategy. BP would have the resources to maximize sales and profits in this approach.

M
Mark Sorenson
5 years ago

I really want you to sell the company I have waited a long time and realize AMRN cant handle V

P
PTA
5 years ago Featured

Secure a generic OR sell to statin BP to market a combo pack stat. Remove the CEO immediately.

E
Eric L · petition starter
5 years ago

This is the right move for patients and shareholders.

A
Anonymous
5 years ago

Shareholder having large stakes. Generic Vascepa please

C
Chris
5 years ago

Please do the right thing.

V
Victor Alan
5 years ago

Take over the market - only move.

M
Max NPV
5 years ago

Agreed...see my name.

A
Anonymous
5 years ago

Must act now!!!!

R
Rehan Asi
5 years ago

Launch and authorized generic now or sell the company.!

J
James Smith
5 years ago

Agree...Make Amarin a Blockbuster

S
Sitansh Patel
5 years ago

Please produce generic version of Vascepa.

W
William R
5 years ago Featured

Dear Mr. Thero, You need to beat generics at their own game. Make it difficult for them to enter the market and gain an edge by making a generic of Vasepa. Cc’d

M
Marcus Teo
5 years ago Featured

Offense is indeed the best defense. Launching generics now may cut our margins in the short run but that is bound to happen when generics arrive. However, we need to eat the humble pie now in order to secure a dominant position in the long run, and fending off generic entry will allow us to retain our majority market share. We urge Amarin not to drop this ball.

K
Kevin cogan
5 years ago

Agree

C
Clayton Johnson
5 years ago

I respectfully approve this!

A
AJ Lane
5 years ago Featured

Mr. Thero, Please do not wait for generics to launch! Contracts should already have been secured with all major pharmacies for Amarin’s VASCEPA to be THE one and only generic offered in the US. Why wait for generics to make the first move? Shut them out NOW and take back 100% of our rightful US market! Signed an extremely dissatisfied owner of 128,400 shares.

A
Anonymous
5 years ago Featured

Both of us have been on Vascepa for 4 years and don't want to be forced to take some junk generic by ins. co.